According to Meridian Bioscience's latest financial reports the company has $81.45 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-09-30 | $81.45 M | 63.66% |
2021-09-30 | $49.77 M | -6.99% |
2020-09-30 | $53.51 M | -14.24% |
2019-09-30 | $62.39 M | 4.41% |
2018-09-30 | $59.76 M | 4.72% |
2017-09-30 | $57.07 M | 20.85% |
2016-09-30 | $47.22 M | -5.5% |
2015-09-30 | $49.97 M | 16.09% |
2014-09-30 | $43.04 M | -2.79% |
2013-09-30 | $44.28 M | 40.16% |
2012-09-30 | $31.59 M | 33.72% |
2011-09-30 | $23.62 M | -37.63% |
2010-09-30 | $37.87 M | -38.22% |
2009-09-30 | $61.31 M | 24.38% |
2008-09-30 | $49.29 M | -0.21% |
2007-09-30 | $49.4 M | 22.43% |
2006-09-30 | $40.34 M | 21.95% |
2005-09-30 | $33.08 M | 1568.43% |
2004-09-30 | $1.98 M | -26.09% |
2003-09-30 | $2.68 M | -12.32% |
2002-09-30 | $3.06 M | -34.57% |
2001-09-30 | $4.67 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $8.07 B | 9,816.15% | ๐บ๐ธ USA |
Becton Dickinson BDX | $1.18 B | 1,351.14% | ๐บ๐ธ USA |
Hologic HOLX | $1.93 B | 2,272.04% | ๐บ๐ธ USA |
QuidelOrtho QDEL | $0.16 B | 105.39% | ๐บ๐ธ USA |